The following case illustrates how surgery may be of use in the palliation of symptoms due to metastatic melanoma.
CASE REPORT
A man aged 37 presented to the surgical oncology clinic with lassitude, shortness of breath on exertion and epigastric discomfort. In 1992 he had a nodular malignant melanoma (Clark level IV, Breslow thickness 0.48 mm) excised from his right calf and a block dissection of iliac, femoral and inguinal nodes. Histology of the lymph nodes revealed metastatic melanoma in 6 of 16 nodes. At this time chest radiograph, computed tomography, full blood count and liver function revealed no evidence of any other tissue involvement. Postoperatively he received five courses of vindesine chemotherapy. He remained disease-free until 2 years later when a recurrence in his left breast was completely excised.
He was clinically anaemic and haemoglobin was 4.7 g/dL (MCV 68 fl.); white cells, platelets and liver function were within normal limits. The anaemia was iron deficient. He was treated with erythropoietin 3000 i.u. twice weekly and oral ferrous sulphate as he was a Jehovah's Witness. Faecal occult blood testing was positive. Upper GI endoscopy and colonoscopy were normal. Computed tomography revealed Department of General Surgery, St Mary's Hospital, Praed Street, London W2,
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Correspondence to: Mr R D Rosin a 'bull's-eye' lesion in the upper small intestine, and small bowel follow-through showed a dilated duodenum and proximal jejunum, with a filling defect in the jejunum at the site of an irregular wall thickening.
It was thought that his anaemia would not respond to erythropoietin. At laparotomy three lesions were found in the upper jejunum and were resected with 6 em margins. An enlarged node in the mesentery was removed but the rest of the abdominal cavity was normal. These lesions and the large node proved to be involved with metastatic melanoma with the histological appearance of the original primary. The patient made an uncomplicated recovery and his haemoglobin returned to normal.
DISCUSSION
Intestinal metastases occur in 60% of patients dying of malignant melanoma but they are discovered in only 5% before death 1. Intestinal metastases may occur up to 20 years following excision of the primary malignant melanoma'. Symptoms of intestinal recurrence are often non-specific 4nausea, early satiety, dyspepsia-and are often ascribed to adjuvant chemotherapy. Metastases occasionally present with perforation or haemorrhage; gastrointestinal blood loss is frank in only 37%4 of patients. Small bowel is most frequently involved, although any site is possible. The metastases are frequently multiple. Only rarely is curative resection possible. Median survival of these patients is 8 months/ and adjuvant chemotherapy does not prolong survival. In conclusion, intestinal metastases cause unpleasant symptoms for which intestinal resection carries a low morbidity and mortality and can provide good palliation.
